Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
san diego blog main
3
×
san diego top stories
boston blog main
boston top stories
clinical trials
deals
fda
new york blog main
rare diseases
startups
abbvie
achaogen
adams street partners
adverum biotechnologies
albert bourla
alzheimer's disease
amgen
amicus therapeutics
antibiotics
arvinas
batten disease
bayer
beta lactamase inhibitor
biogen
biomedical advanced research and development authority (barda)
biotech ipos
boston
boulder/denver blog main
boulder/denver top stories
breast cancer
brian stuglik
cancer diagnostics
cancer immunotherapy
casimir trials
celenex
christine mcsherry
chuck schumer
What
company
3
×
drug
3
×
medicines
therapeutics
acquisitions
albert
bacteria
biggest
bio
biopharma
bourla
brings
business
ceo
crispr
developing
disease
disorders
dyne
dyne’s
exited
fighting
future
genetic
imports
infections
infectious
ipo
launches
maker
maps
measured
melinta
million
muscle
muscular
patients
pfizer
pfizer’s
preclinical
Language
unknown
unset
Current search:
drug
×
company
×
" san diego blog main "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
